Related Experiment Video

Updated: Jul 2, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Revascularization treatment recommendations based on atherosclerotic disease distribution: coronary artery bypass

Kim I de la Cruz1, Peter I Tsai, William E Cohn

  • 1Texas Heart Institute, MC 3-258, PO Box 20345, Houston, TX 77225, USA.

Current Atherosclerosis Reports
|August 19, 2008
PubMed

Insights

For coronary artery disease, treatment choice depends on disease extent. Revascularization (CABG or PCI) benefits multivessel disease patients, while CABG offers better outcomes in complex cases.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Coronary artery disease (CAD) necessitates refined treatment strategies based on atherosclerotic distribution.
  • Efficacy of medical therapy versus percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) remains a key research area.

Purpose of the Study:

  • To review clinical trials and clarify treatment recommendations for coronary artery disease.
  • To compare outcomes of medical therapy, PCI, and CABG based on CAD complexity and patient factors.

Main Methods:

  • Systematic review of relevant clinical trials evaluating different treatment modalities for CAD.
  • Analysis of patient subgroups based on coronary artery involvement, ischemia, and comorbidities.

Main Results:

  • One- and two-vessel CAD without left main or left anterior descending involvement show similar outcomes with any treatment.
  • Multivessel disease with inducible ischemia is best managed with revascularization (CABG or PCI).
  • CABG demonstrates superior outcomes in survival, angina relief, and intervention-free status for patients with left main disease, diffuse atherosclerosis, diabetes, advanced age, or left ventricular dysfunction.

Conclusions:

  • Treatment decisions for coronary artery disease should be tailored to the specific distribution and severity of atherosclerotic disease.
  • Revascularization strategies, particularly CABG, offer significant advantages in complex CAD scenarios and specific patient populations.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...